🇨🇦 ClinSupV3ER- Extended release tablet in Canada

ClinSupV3ER- Extended release tablet (ClinSupV3ER- Extended release tablet) regulatory status in Canada.

Marketing authorisation

ClinSupV3ER- Extended release tablet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ClinSupV3ER- Extended release tablet approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for ClinSupV3ER- Extended release tablet in Canada?

Dr Bharti Daswani is the originator. The local marketing authorisation holder may differ — check the official source linked above.